The Canadian Association of Pharmacy in Oncology (CAPhO), is a proud Canadian organization that represents oncology pharmacy in Canada, where values such as inclusivity, equitable access to healthcare, and evidence-based medicine matter.
This survey assesses CAR T cell therapy use in DLBCL, focusing on educational gaps in awareness, barriers to use, and adverse event management. Your confidential input will optimize clinical practice and improve outcomes.
In accordance with CAPhO’s bylaws, the Board of Directors’ election for director positions will be held electronically prior to the Annual General Meeting (AGM) for the duration of two weeks in February 2025.
Registration is open! Register by the Early Bird deadline of Wednesday, January 15 to save! Visit the Symposium registration page for information on registration fees and deadlines.
